Mathes Company, Inc. BCAT — Blackrock Capital Allocation Trust

Ownership history in Mathes Company, Inc.  ·  21 quarters on record

AI Ownership Summary

Mathes Company, Inc. reported Blackrock Capital Allocation Trust (BCAT) in 21 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.62% in 2025 Q1. The latest visible filing shows BCAT at 0.44% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this BCAT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Mathes Company, Inc.'s position in Blackrock Capital Allocation Trust, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

BCAT was reported at 0.44% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.62% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

BCAT stock page Mathes Company, Inc. fund profile Mathes Company, Inc. full holdings
How Mathes Company, Inc. held BCAT — position size vs. price
% of Fund (quarterly)    BCAT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 18.0% +5.2% ❌ 86,500 -19,000 -18.0% 0.44% $1.2M 2026-02-14 (Est.) $14.44
2025 Q3 UNCHANGED — — — 105,500 — 0% 0.56% $1.6M 2025-11-12 $13.18
2025 Q2 UNCHANGED — — — 105,500 — 0% 0.59% $1.6M 2025-08-05 $12.69
2025 Q1 REDUCED — — — 105,500 -4,300 -3.9% 0.62% $1.5M 2025-05-01 $11.87
2024 Q4 ADDED — — — 109,800 +13,300 +13.8% 0.61% $1.7M 2025-01-31 $11.75
2024 Q3 ADDED — — — 96,500 +5,500 +6.0% 0.56% $1.6M 2024-10-29 $11.34
2024 Q2 REDUCED — — — 91,000 -2,500 -2.7% 0.54% $1.5M 2024-08-12 $11.08
2024 Q1 REDUCED — — — 93,500 -2,250 -2.3% 0.58% $1.6M 2024-05-02 $10.35
2023 Q4 REDUCED 5.9% +13.9% ❌ 95,750 -6,000 -5.9% 0.59% $1.4M 2024-01-30 $9.90
12 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding BCAT

As of 2026 Q1 — sorted by position size

WINEBRENNER CAPITAL MANAGEMENT LLC 0.37% Formidable Asset Management, LLC 3Y 7Y 0.14% EVOLVE PRIVATE WEALTH, LLC 0.07% PFG Investments, LLC 0.06% Amplius Wealth Advisors, LLC 3Y 0.04% EAGLE ROCK INVESTMENT COMPANY, LLC 3Y 0.04% Walkner Condon Financial Advisors LLC 3Y 0.03% Patriot Financial Group Insurance Agency, LLC 3Y 7Y 0.03% SeaCrest Wealth Management, LLC 3Y 7Y 0.02% KINGSWOOD WEALTH ADVISORS, LLC 0.02%

FAQ About Mathes Company, Inc. and BCAT

These are the practical questions this page is built to answer before you even open the full history table.

How long has Mathes Company, Inc. reported owning BCAT?

Mathes Company, Inc. reported BCAT across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported BCAT position in Mathes Company, Inc.'s portfolio?

The largest reported portfolio weight for BCAT was 0.62% in 2025 Q1.

What is the latest reported BCAT position on this page?

The most recent filing on this page is 2025 Q4, when Mathes Company, Inc. reported 86,500 shares, equal to 0.44% of portfolio, with an estimated market value of $1.2M.

What does the chart on this BCAT ownership page compare?

The chart compares Mathes Company, Inc.'s quarterly BCAT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Mathes Company, Inc. time their BCAT position?

Based on 13F filing dates vs. subsequent BCAT price moves, Mathes Company, Inc. correctly timed 9 out of 18 reported position changes (50%). The annualised alpha on BCAT relative to SPY over the holding period was -7.2%.

← Back to Mathes Company, Inc. Holdings